Reactive "Sick Care" System Drives Unsustainable Healthcare Costs

This conversation with David Cordani, CEO of The Cigna Group, reveals a critical disconnect in American healthcare: the pervasive focus on treating sickness rather than proactively cultivating health. Cordani argues that the current system, driven by demand for more expensive care and increasingly costly treatments, is unsustainable. The hidden consequence? A compounding cycle of chronic conditions and escalating costs that disproportionately burdens individuals and employers. This analysis is crucial for business leaders, policymakers, and anyone seeking to understand the systemic forces driving healthcare expenses and the potential pathways toward a more sustainable, health-focused future.

The Unseen Cost of Reactive Care: Why "Sick Care" Fails Us

The prevailing approach to American healthcare is fundamentally misaligned with long-term well-being. David Cordani, CEO of The Cigna Group, articulates a core problem: the system is overwhelmingly geared towards "sick care" intervention, spending the vast majority of its resources on treating ailments after they manifest. This reactive stance, while addressing immediate needs, creates a cascade of downstream effects that inflate costs and diminish overall health outcomes. The immediate benefit of treating a sickness is clear, but the hidden cost is the missed opportunity to prevent it in the first place.

Cordani highlights that this imbalance is not a recent development. He points to a stark historical contrast: in the 1970s, medical cost growth closely tracked inflation. However, over the last 25 years, medical costs have escalated at approximately three times the rate of inflation. This acceleration, he argues, is driven by two undeniable forces: a global decline in health profiles, particularly concerning chronic conditions, and a concurrent rise in the cost of interventions. The system, by its very design, incentivizes volume over value, leading to a perpetual cycle of escalating expenses.

"The US spends the vast majority of its resources fixing sickness after it occurs. We need to spend more resources on helping individuals maintain their health."

This emphasis on fixing sickness rather than fostering health has profound implications. Employers, who form the backbone of healthcare access for a significant portion of the US population, are increasingly confronting the mental and physical toll on their workforces. Cordani notes that the pandemic amplified this realization, pushing CEOs to seek alternative strategies beyond simply treating illness. The gateway to more serious health challenges, he explains, often begins with elevated stress and anxiety. By failing to address these early-stage mental health issues, the system inadvertently allows them to blossom into more complex and costly physical and psychological conditions. This creates a compounding problem: the initial avoidance of preventative mental healthcare leads to a greater demand for more intensive, expensive interventions down the line.

The Employer's Dilemma: Navigating the Cost-Benefit of Proactive Health

The employer market, as Cordani emphasizes, is a critical lever in the US healthcare ecosystem. Employers, through their health plans, shape the health behaviors and outcomes of millions. However, they are caught in a difficult bind. The current system often makes it more economically expedient to address acute issues as they arise rather than investing in long-term preventative programs. This is where conventional wisdom falters when extended forward. A short-term focus on immediate cost containment through minimal benefits can lead to greater long-term expenses due to unaddressed chronic conditions and mental health crises.

Cordani outlines a more effective, albeit less immediately gratifying, approach: investing in programs that keep healthy individuals healthy and identify those at risk before they develop chronic conditions. This includes proactive measures like identifying pre-diabetic individuals or those at high risk for other conditions, and ensuring adherence to evidence-based care for those already managing chronic illnesses. The immediate payoff for these interventions might be delayed--perhaps not visible in quarterly reports--but the long-term advantage is substantial. It shifts the paradigm from a costly reactive model to a more sustainable, proactive one.

"Second, the category least spoken about is any group of individuals, you could take the country as a whole, we could take a state, you could take a city, you could take an employer, has a percentage of the population that appears to be healthy because they have low medical cost claims or very little, but they have high health risks because of lifestyle behavior or genetic predisposition."

The challenge for employers, and by extension insurers like Cigna, lies in shifting incentives. Cordani advocates for a system where money is spent based on clinical outcomes, not just consumption. This requires a move away from a purely volume-based model towards one that rewards value and demonstrable health improvements. This is particularly relevant in complex healthcare situations, such as those involving centers of excellence or chronic care optimization programs. The delayed payoff of these outcome-based approaches--better health at a lower long-term cost--creates a competitive advantage for those organizations willing to invest in them, even if the initial groundwork requires more effort and patience.

The Illusion of "Fixed": Why Systemic Change Demands More Than Incremental Tweaks

Cordani's perspective on fixing the American healthcare system transcends simple policy adjustments; it calls for a fundamental reorientation. He identifies three major areas for improvement, each requiring a departure from the status quo: increased investment in preventative and whole-person care, a shift from volume-based to value-based spending, and a more aggressive harnessing of competition. The current system's reliance on "sick care" is a direct consequence of these areas being underdeveloped.

The disparity between US healthcare spending and life expectancy compared to other developed nations underscores the inefficiency of the current model. While the US spends a significant portion of its GDP on healthcare, its life expectancy lags behind countries like Switzerland and Italy, which spend considerably less. This suggests that simply spending more money is not the solution; how that money is spent is paramount. Cordani points to a shortage of primary care physicians, OBGYNs, pediatricians, and geriatricians as a symptom of a system that doesn't adequately incentivize preventative and foundational care.

"Why have so many other first-world countries figured out how to do this and we have not?"

Furthermore, the system's reliance on volume-based reimbursement means that providers are often rewarded for the quantity of services rendered, not necessarily the quality or outcome of those services. This creates a perverse incentive structure where more procedures, more tests, and more prescriptions, even if not strictly necessary, can lead to higher revenue. The delayed payoff of a truly value-based system--where providers are incentivized for keeping patients healthy and managing chronic conditions effectively--is a significant competitive advantage that the current model actively suppresses. The disruption caused by prioritizing transparency, even if it challenges existing business models within hospitals and pharmaceuticals, is presented as a necessary step towards a more equitable and efficient system. This willingness to embrace disruptive transparency, even at the cost of short-term comfort, is precisely where lasting advantage can be forged.

Key Action Items:

• Immediate Action (Next Quarter):
  • Launch internal awareness campaigns on the link between mental well-being and overall health, destigmatizing seeking support.
  • Audit current benefits packages to identify gaps in mental health coverage and access to virtual therapy options.
  • Initiate dialogue with HR leadership to explore pilot programs focused on identifying individuals at high health risk (e.g., pre-diabetic screenings).
• Near-Term Investment (Next 6-12 Months):
  • Invest in robust employee assistance programs (EAPs) that offer comprehensive mental health support and counseling services.
  • Explore partnerships with healthcare providers focused on value-based care models, prioritizing preventative and chronic condition management.
  • Advocate for increased transparency in healthcare pricing and benefit utilization within your organization and industry.
• Long-Term Strategic Play (12-18+ Months):
  • Develop and implement comprehensive wellness programs that foster a culture of preventative health, rewarding proactive engagement.
  • Champion outcome-based reimbursement models with healthcare partners, shifting focus from volume to demonstrable patient health improvements.
  • Build community activation initiatives that encourage employee volunteerism and connection, recognizing their positive impact on mental well-being and belonging.